The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1?rss=1%22&utm_source=dlvr.it&utm_medium=tumblr
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1?rss=1%22&utm_source=dlvr.it&utm_medium=tumblr